Vivid Seats 10-K/A10 May 212020 FY Annual report (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	7 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2020	Mar. 31, 2021
Document Information [Line Items]
Document Type	10-K/A
Document Period End Date	Dec. 31, 2020
Entity Registrant Name	Horizon Acquisition Corp
Entity Current Reporting Status	Yes
Transition Report	true
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001817071
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	true
Document Annual Report	true
Document Transition Report	false
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float	$ 545,072,299
Amendment Description	(Amendment No.1)
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	HZAC.U
Security Exchange Name	NYSE
Class A ordinary shares
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	HZAC
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		54,398,433
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	HZAC WS
Security Exchange Name	NYSE
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		13,599,608

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current assets:
Cash	$ 941,474
Prepaid expenses	333,528
Total current assets	1,275,002
Investments held in Trust Account	544,002,795
Total Assets	545,277,797
Current liabilities:
Accounts payable	103,824
Accrued expenses	340,625
Total current liabilities	444,449
Derivative warrant liabilities	35,746,280
Deferred underwriting commissions	13,614,452
Total liabilities	49,805,181
Commitments and Contingencies (Note 6)
Class A ordinary shares; 49,047,261 shares subject to possible redemption at $10.00 per share	490,472,610
Shareholders' Equity:
Additional paid-in capital	22,614,159
Accumulated deficit	(17,616,048)
Total shareholders' equity	5,000,006
Total Liabilities and Shareholders' Equity	545,277,797
Class A ordinary shares
Shareholders' Equity:
Ordinary shares	535
Class B ordinary shares
Shareholders' Equity:
Ordinary shares	1,360
Additional paid-in capital	$ 22,614,159

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical) - $ / shares	Dec. 31, 2020	Oct. 04, 2020	Sep. 30, 2020	Aug. 25, 2020
Shares subject to possible redemption	49,047,261
Shares subject to possible redemption, par value per share	$ 10		$ 0.0001	$ 0.0001
Preference shares, par value	$ 0.0001		$ 0.0001	0.0001
Preference shares, shares authorized	1,000,000
Preference shares, shares issued	0
Preference shares, shares outstanding	0
Over-allotment
Ordinary shares, shares authorized	7,500,000
Class A ordinary shares
Shares subject to possible redemption	49,047,261		49,047,261
Shares subject to possible redemption, par value per share	$ 0.0001
Ordinary shares, par value	$ 0.0001		$ 0.0001	0.0001
Ordinary shares, shares authorized	400,000,000
Ordinary shares, shares issued	5,351,172
Ordinary shares, shares outstanding	5,351,172
Class B ordinary shares
Ordinary shares, par value	$ 0.0001		$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	40,000,000
Ordinary shares, shares issued	13,599,608
Ordinary shares, shares outstanding	13,599,608
Class B ordinary shares \| Over-allotment
Maximum shares subject to forfeiture		194,142

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS	7 Months Ended
STATEMENTS OF OPERATIONS	Dec. 31, 2020USD ($)$ / sharesshares
General and administrative expenses	$ 538,313
Loss from operations	(538,313)
Change in fair value of derivative warrant liabilities	(16,517,250)
Financing cost - derivative warrant liabilities	(578,950)
Net gain from investments held in Trust Account	18,465
Net loss	$ (17,616,048)
Class A ordinary shares
Other income:
Basic and diluted weighted average shares outstanding \| shares	54,364,337
Basic and diluted net income per share \| $ / shares	$ 0
Class B ordinary shares
Other income:
Basic and diluted weighted average shares outstanding \| shares	13,269,125
Basic and diluted net income per share \| $ / shares	$ (1.33)

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Class A ordinary sharesOrdinary shares	Class B ordinary sharesOrdinary shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jun. 11, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jun. 11, 2020	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(16,744,623)
Balance at the end at Sep. 30, 2020					5,000,001
Balance at the beginning at Jun. 11, 2020	$ 0	$ 0	0	0	0
Balance at the beginning (in shares) at Jun. 11, 2020	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsors		$ 1,438	23,562		25,000
Issuance of Class B ordinary shares to Sponsors (in shares)		14,375,000
Sale of units in initial public offering, less fair value of public warrants	$ 5,440		529,835,300		529,840,740
Sale of units in initial public offering, less fair value of public warrants (in shares)	54,398,433
Offering costs			(21,471,323)		(21,471,323)
Excess of cash received over fair value of private placement warrants			4,694,247		4,694,247
Forfeiture of Class B ordinary shares		$ (78)	78
Forfeiture of Class B ordinary shares (in shares)		(775,392)
Shares subject to possible redemption	$ (4,905)		(490,467,705)		(490,472,610)
Shares subject to possible redemption (in shares)	(49,047,261)
Net loss				(17,616,048)	(17,616,048)
Balance at the end at Dec. 31, 2020	$ 535	$ 1,360	$ 22,614,159	$ (17,616,048)	$ 5,000,006
Balance at the end (in shares) at Dec. 31, 2020	5,351,172	13,599,608

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	7 Months Ended
STATEMENT OF CASH FLOWS	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (17,616,048)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000
Change in fair value of derivative warrant liabilities	16,517,250
Financing cost - derivative warrant liabilities	578,950
Net (gain) loss on investments held in Trust Account	(18,465)
Changes in operating assets and liabilities:
Accounts payable	18,824
Prepaid expenses	(333,528)
Accrued expenses	340,625
Net cash used in operating activities	(487,392)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(543,984,330)
Net cash used in investing activities	(543,984,330)
Cash Flows from Financing Activities:
Borrowings under note payable to Sponsor	(184,835)
Proceeds received from initial public offering, gross	543,984,330
Proceeds received from private placement	9,779,687
Offering costs paid	(8,165,986)
Net cash provided by financing activities	545,413,196
Net change in cash	941,474
Cash - beginning of the period	0
Cash - end of the period	941,474
Supplemental disclosure of noncash investing and financing activities:
Offering costs paid through note payable to Sponsor	184,835
Offering costs included in accrued expenses	85,000
Forfeiture of Class B ordinary shares	78
Deferred underwriting commissions	13,614,452
Initial value of Class A ordinary shares subject to possible redemption	507,479,670
Change in value of Class A ordinary shares subject to possible redemption	(17,007,060)
Initial fair value of warrant liabilities	$ 19,229,030

DESCRIPTION OF ORGANIZATION, BU

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION	7 Months Ended
	Dec. 31, 2020
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION Organization and General Horizon Acquisition Corporation, (the "Company") formerly known as EAC Holdings Inc., is a blank check company incorporated in the Cayman Islands on June 12, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“initial Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus in the financial, technology and business services sectors. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”). As of December 31, 2020, the Company had not yet commenced operations. All activity for the period from June 12, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. Sponsor and Initial Public Offering The Company’s sponsor is Horizon Sponsor, LLC, a Delaware limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 20, 2020. On August 25, 2020, the Company consummated its Initial Public Offering of 50,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $500.0 million, and incurring offering costs of approximately $19.6 million, inclusive of approximately $12.1 million in deferred underwriting commissions (Note 7). On August 26, 2020, the Company issued an additional 4,398,433 Units at the Initial Public Offering price at $10.00 per Unit pursuant to the exercise by the underwriters of a portion of their over-allotment option, generating additional gross proceeds of approximately $44.0 million, and incurring additional offering costs of approximately $2.4 million, inclusive of an additional of approximately $1.5 million in deferred underwriting commissions. Simultaneously, with the consummation of the Initial Public Offering, the Company consummated the private placement (the “Private Placement”) of 5,933,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $8.9 million (Note 5). In connection with the exercise by the underwriters of the over-allotment option, the Sponsor purchased an additional 586,458 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating additional total proceeds of approximately $0.9 million. Trust Account Upon the closing of the Initial Public Offering and the Private Placement on August 25, 2020, approximately $500.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”), with Continental Stock Transfer & Trust Company acting as trustee. On August 26, 2020, an additional amount of approximately $44.0 million, for a total of approximately $544.0 million was deposited to the Trust Account. The proceeds in the Trust Account are invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target business or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. The Company will provide the holders of its the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). These Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which was adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether they were a Public Shareholder on the record date for the general meeting held to approve the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the founder shares prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their founder shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their founder shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association to either (i) to modify the substance or timing of the Company’s obligation to allow the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering or (ii) with respect to any other provisions relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or August 25, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders have agreed to waive their liquidation rights with respect to the founder shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution in the Trust Account will be less than the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. There can be no guarantee that the Company will be successful in obtaining such waivers from its targeted vendors and service providers. Basis of presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements as of August 25, 2020, as of and the period from June 12, 2020 (inception) through December 31, 2020, and the unaudited interim financial statements as of, and for the three months ended September 30, 2020 and period from June 12, 2020 (inception) through September 30,2020 (collectively, the “Affected Periods”), are restated in this Annual Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial Statements for further discussion. Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with other public companies difficult or impossible because of the potential differences in accounting standards used. Liquidity and Capital Resources As of December 31, 2020, the Company had approximately $941,000 outside of the Trust Account and working capital of approximately $831,000. The Company’s liquidity needs up to December 31, 2020 have been satisfied through (i) the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the founder shares, (ii) a loan of approximately $185,000 from the Sponsor (see Note 6), and (iii) the proceeds from the consummation of the Private Placement, the proceeds of which are not held in the Trust Account. The Company fully repaid the loan from the Sponsor on August 28, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). As of December 31, 2020, there were no amounts outstanding under any Working Capital Loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of an Initial Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	7 Months Ended
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance in August 2020, the Company’s warrants were accounted for as equity within the Company’s previously reported balance sheets. After discussion and evaluation, including with the Company’s independent registered public accounting firm and the Company’s audit committee, management concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued in August, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued Financial Statements for the Affected Periods should be restated because of a misapplication in the guidance around accounting for certain of our outstanding Warrants to purchase ordinary shares and should no longer be relied upon. Impact of the Restatement The impact of the restatement on the audited consolidated balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 545,277,797 $ — $ 545,277,797 Liabilities and shareholders’ equity Total current liabilities $ 444,449 $ — $ 444,449 Deferred underwriting commissions 13,614,452 — 13,614,452 Derivative warrant liabilities — 35,746,280 35,746,280 Total liabilities 14,058,901 35,746,280 49,805,181 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 526,218,890 (35,746,280) 490,472,610 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 178 357 535 Class B ordinary shares - $0.0001 par value 1,360 — 1,360 Additional paid-in-capital 5,518,316 17,095,843 22,614,159 Accumulated deficit (519,848) (17,096,200) (17,616,048) Total shareholders’ equity 5,000,006 — 5,000,006 Total liabilities and shareholders’ equity $ 545,277,797 $ — $ 545,277,797 Period From June 12, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Operations Loss from operations $ (538,313) $ — $ (538,313) Other (expense) income: Change in fair value of derivative warrant liabilities — (16,517,250) (16,517,250) Financing cost -derivative warrant liabilities — (578,950) (578,950) Net gain from investments held in Trust Account 18,465 — 18,465 Total other (expense) income 18,465 (17,096,200) (17,077,735) Net loss $ (519,848) $ (17,096,200) $ (17,616,048) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,364,337 54,364,337 Basic and Diluted net loss per Class A share $ 0.00 $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 13,269,125 13,269,125 Basic and Diluted net loss per Class B share $ (0.04) $ (1.29) $ (1.33) Period From June 12, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Cash Flows Net loss $ (519,848) $ (17,096,200) $ (17,616,048) Adjustment to reconcile net loss to net cash used in operating activities 32,456 17,096,200 17,128,656 Net cash used in operating activities (487,392) — (487,392) Net cash used in investing activities (543,984,330) — (543,984,330) Net cash provided by financing activities 545,413,196 — 545,413,196 Net change in cash $ 941,474 $ — $ 941,474 In addition, the impact to the balance sheet dated August 25, 2020, filed on Form 8-K on August 31, 2020 is presented below. As of August 25, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 503,263,387 $ — $ 503,263,387 Liabilities and shareholders’ equity Total current liabilities $ 1,044,874 $ — $ 1,044,874 Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 17,628,000 17,628,000 Total liabilities 13,119,874 17,628,000 30,747,874 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 485,143,510 (17,628,000) 467,515,510 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 149 176 325 Class B ordinary shares - $0.0001 par value 1,380 — 1,380 Additional paid-in-capital 5,028,513 578,774 5,607,287 Accumulated deficit (30,039) (578,950) (608,989) Total shareholders’ equity 5,000,003 — 5,000,003 Total liabilities and shareholders’ equity $ 503,263,387 $ — $ 503,263,387 For the impact of the restatement of the quarterly interim period (unaudited) of September 30, 2020, see Note 12.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	7 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020. Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. The Company’s investments held in the Trust Account as of December 31, 2020 is comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities money market funds. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, prepaid expenses accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. government securities with an original maturity of 185 days or less or investments in a money market funds that invest in only U.S. government securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets. The fair value of warrants issued in connection with the Initial Public Offering, exercise of the over-allotment option and Private Placement were initially and subsequently measured at fair value using a Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants have been measured based on the listed market price of such Public Warrants. The Private Placement Warrants continue to be measured at fair value using a Monte Carlo simulation model through December 31, 2020. Offering Costs Associated with Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity. Of the total offering costs of the Initial Public Offering, approximately $0.6 million is included in financing cost - derivative warrant liabilities in the statement of operations and $21.5 million is included in stockholders’ equity. Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2020, 49,047,261 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the balance sheet. Derivative Warrant liabilities The Company did not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. Management evaluates all of its financial instruments, including issued warrants to purchase Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company issued an aggregate of 18,132,811 warrants on Class A ordinary shares in the Initial Public Offering and upon the underwriters exercise of a portion of their over-allotment option, and issued 6,519,791 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjusted the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering, exercise of the over-allotment option and Private Placement were initially and subsequently measured at fair value using a Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants have been measured based on the listed market price of such Public Warrants The Private Placement Warrants continue to be measured at fair value using a Monte Carlo simulation model through December 31, 2020. Net Income (loss) per Ordinary Share Net loss per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 24,652,602 shares of Class A ordinary shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted loss per share is the same as basic loss per share for the periods presented. The Company’s statement of operations includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted, for Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account of approximately $18,000 for the period from June 12, 2020 (inception) through December 31, by the weighted average number of shares of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted, for Class B ordinary shares is calculated by dividing the net loss of approximately $17.6 million for the period from June 12, 2020 (inception) through December 31, 2020, less income attributable to Class A ordinary shares, by the weighted average number of shares of Class B ordinary shares outstanding for the period. Income taxes FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	7 Months Ended
INITIAL PUBLIC OFFERING	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING On August 25, 2020, the Company consummated its Initial Public Offering of 50,000,000 Units, at $10.00 per Unit, generating gross proceeds of $500.0 million, and incurring offering costs of approximately $19.6 million, inclusive of approximately $12.1 million in deferred underwriting commissions. The Sponsor purchased 15,500,000 Units (the “Affiliated Units”) at the Initial Public Offering price. The underwriters did not receive any underwriting discounts or commissions on the Affiliated Units. On August 26, 2020, the Company issued an additional of 4,398,433 Units at the Initial Public Offering price at $10.00 per Unit pursuant to the exercise by the underwriters of a portion of their over-allotment option, generating additional gross proceeds of approximately $44.0 million, and incurring additional offering costs of approximately $2.4 million, inclusive of an additional of approximately $1.5 million in deferred underwriting commissions. Each Unit will consist of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

PRIVATE PLACEMENT

PRIVATE PLACEMENT	7 Months Ended
PRIVATE PLACEMENT	Dec. 31, 2020
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT As a result of the purchase of the Affiliated Units by the Sponsor, the number of Private Placement Warrants purchased by the Sponsor was reduced to account for the corresponding reduction in underwriting discounts payable upon completion the Initial Public Offering. On August 25, 2020, simultaneous with the consummation of the Initial Public Offering, the Company consummated the Private Placement of 5,933,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $8.9 million. In connection with the partial exercise of the over-allotment option, the Sponsor purchased an additional 586,458 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating additional total proceeds of approximately $0.9 million. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable except as described below in Note 8 and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	7 Months Ended
RELATED PARTY TRANSACTIONS	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On July 2, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 Class B ordinary shares (the “founder shares”). The Sponsor agreed to forfeit up to an aggregate of 1,875,000 founder shares to the extent that the option to purchase additional units was not exercised in full by the underwriters or was reduced, so that the founder shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On August 25, 2020, in connection with the purchase of the Affiliated Units, the Sponsor surrendered 581,250 founder shares to the Company for no consideration. On August 26, 2020, the underwriters partially exercised their over-allotment option, which resulted in 1,099,608 founder shares no longer being subject to forfeiture. On October 4, 2020, 194,142 shares were forfeited as the remainder of the over-allotment option expired unexercised. As a result, as of December 31, 2020, no remaining Class B ordinary shares were subject to forfeiture. The Initial Shareholders agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, capitalization of shares, share dividends, rights issuances, subdivisions reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the initial Business Combination, and (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Related Party Loans On July 2, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed approximately $185,000 under the Note, and fully repaid this balance on August 28, 2020. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2020, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement The Company agreed to pay the Sponsor a total of $10,000 per month, commencing on the date of listing on the NYSE, for office space, utilities, secretarial and administrative support services provided to members of the management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. From the date the securities were first listed on the NYSE through December 31, 2020, the Sponsor waived the fee. In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Audit Committee of the Board of Directors will review on a quarterly basis all payments that are made by the Company to the Sponsor, officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	7 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 7. COMMITMENTS AND CONTINGENCIES Registration and Shareholder Rights The holders of the founder shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45‑day option, from August 20, 2020, the date of the final prospectus related to the initial public offering, to purchase up to 7,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On August 26, 2020, the Company issued an additional of 4,398,433 Units at the Initial Public Offering price at $10.00 per Unit pursuant to the partial exercise of the underwriters’ over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $6.9 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $12.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In connection with the consummation of the sale of Units pursuant to the over-allotment option on August 26, 2020, the underwriters were entitled to an additional fee of approximately $0.9 million paid upon closing and an additional deferred underwriting commissions of approximately $1.5 million. Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that, while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES	7 Months Ended
DERIVATIVE WARRANT LIABILITIES	Dec. 31, 2020
DERIVATIVE WARRANT LIABILITIES
DERIVATIVE WARRANT LIABILITIES	NOTE 8. DERIVATIVE WARRANT LIABILITES As of December 31, 2020, the Company had 18,132,811 and 6,519,791 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an initial Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any founder shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10‑trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See “— Redemption of warrants when the price per class A ordinary share equals or exceeds $18.00” and “— Redemption of warrants when the price per class A ordinary share equals or exceeds $10.00” as described below. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or such its permitted transferees and (iii) the Sponsor or its permitted transferees will have the option to exercise the Private Placement Warrants on a cashless basis and have certain registration rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): · in whole and not in part; · at a price of $0.01 per warrant; · upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and · if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): · in whole and not in part; · at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; · if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30‑trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and · if the closing price of the Class A ordinary shares for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	7 Months Ended
SHAREHOLDERS' EQUITY	Dec. 31, 2020
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY	NOTE 9. SHAREHOLDERS’ EQUITY Class A Ordinary Shares — The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2020, there were 54,398,433 Class A ordinary shares issued and outstanding, including 49,047,261 Class A ordinary shares subject to possible redemption and have been reflected as temporary equity on the balance sheet. Class B Ordinary Shares — The Company is authorized to issue 40,000,000 Class B ordinary shares with a par value of $0.0001 per share. On July 2, 2020, the Company issued 14,375,000 Class B ordinary shares, of which an aggregate of up to 1,875,000 Class B ordinary shares were subject to forfeiture to the Company by the Initial Shareholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Initial Shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On August 25, 2020, in connection with the purchase of the Affiliated Units, the Sponsor surrendered 581,250 founder shares to the Company for no consideration. On August 26, 2020, the underwriters partially exercised their over-allotment option, which resulted in 1,099,608 founder shares no longer being subject to forfeiture. As a result, 194,142 Class B ordinary shares were subject to forfeiture. On October 4, 2020, these shares were forfeited as the remainder of the over-allotment option expired unexercised. As of December 31, 2020, there were 13,599,608 Class B ordinary shares outstanding, and no shares were subject to forfeiture. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law; provided that only holders of Class B ordinary shares will have the right to vote on the appointment of directors prior to, or in connection with, the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one-for-one basis. Preference Shares — The Company is authorized to issue 1,000,000 preference with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2020, there were no preference shares issued or outstanding.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	7 Months Ended
FAIR VALUE MEASUREMENTS	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Quoted Significant Significant Prices Other Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 544,002,795 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 26,292,580 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 9,453,700 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in October 2020, when the Public Warrants were separately listed and traded. Level 1 instruments include investments in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently through September 30, 2020. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants, a Level 1 measurement, since October 2020. The Private Placement Warrants continue to be measured at fair value using a Monte carlo simulation model through December 31, 2020. For the period ended December 31, 2020, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of approximately $16.5 million presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. The estimated fair value of the Public Warrants prior to being separately listed and traded, and the Private Placement Warrants were determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs at the initial measurement date: As of August 25, 2020 As of December 31, 2020 Volatility Share price $ 9.74 $ 10.02 Risk-free rate Dividend yield The change in the fair value of the derivative warrant liabilities for the period from June 12, 2020 (inception) through December 31, 2020 is summarized as follows: Warrant liabilities at June 12, 2020 (inception) $ — Issuance of Public and Private Warrants 19,229,030 Change in fair value of warrant liabilities 16,517,250 Warrant liabilities at December 31, 2020 $ 35,746,280

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	7 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated events that have occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than the event disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements which have not previously been disclosed within the financial statements. On April 21, 2021, the Company entered into a Transaction Agreement with Hoya Topco, LLC (“Topco”), a Delaware limited liability company, Hoya Intermediate, LLC (“Intermediate”), a Delaware limited liability company, and Vivid Seats Inc. (“VS PubCo”), a Delaware corporation and a direct wholly owned subsidiary of Intermediate, pursuant to which the Company will merge with and into VS PubCo, and VS PubCo will be the surviving corporation of the merger. For further details on the contemplated merger, please see the Form 8-K filed with the Securities and Exchange Commission on April 22, 2021.

QUARTERLY FINANCIAL INFORMATION

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	7 Months Ended
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	Dec. 31, 2020
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	NOTE 12. QUARTERLY FINANCIAL INFORMATION (UNAUDITED) The following tables contain unaudited consolidated quarterly financial information for the quarterly period ended September 30, 2020 that has been updated to reflect the restatement and revision of the Company’s consolidated financial statements as described in Note 2—Restatement of Previously Issued Financial Statements. The restatement did not have any impact on the Company’s liquidity, cash flows, revenues or costs of operating its business. The Company has not amended its previously filed Quarterly Report on Form 10-Q for the Affected Period. The financial information that has been previously filed or otherwise reported for the Affected Period is superseded by the information in this Annual Report, and the financial statements and related financial information for the Affected Period contained in such previously filed report should no longer be relied upon. As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 545,356,337 $ — $ 545,356,337 Liabilities and shareholders’ equity Total current liabilities $ 144,624 $ — $ 144,624 Deferred underwriting commissions 13,614,452 — 13,614,452 Derivative warrant liabilities — 35,253,220 35,253,220 Total liabilities 13,759,076 35,253,220 49,012,296 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 526,597,260 (35,253,220) 491,344,040 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 174 352 526 Class B ordinary shares - $0.0001 par value 1,379 — 1,379 Additional paid-in-capital 5,139,931 16,602,788 21,742,719 Accumulated deficit (141,483) (16,603,140) (16,744,623) Total shareholders’ equity 5,000,001 — 5,000,001 Total liabilities and shareholders’ equity $ 545,356,337 $ — $ 545,356,337 Three Months Ended September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (126,442) $ — $ (126,442) Other (expense) income: Change in fair value of derivative warrant liabilities — (16,024,190) (16,024,190) Financing cost - derivative warrant liabilities — (578,950) (578,950) Net gain from investments held in Trust Account 2,139 — 2,139 Total other (expense) income 2,139 (16,603,140) (16,601,001) Net loss $ (124,303) $ (16,603,140) $ (16,727,443) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,279,556 54,279,556 Basic and Diluted net loss per Class A share $ — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 12,935,010 12,935,010 Basic and Diluted net loss per Class B share $ (0.01) $ (1.28) $ (1.29) Period From June 12, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (143,622) $ — $ (143,622) Other (expense) income: Change in fair value of warrant liabilities — (16,024,190) (16,024,190) Financing cost — (578,950) (578,950) Net gain from investments held in Trust Account 2,139 — 2,139 Total other (expense) income 2,139 (16,603,140) (16,601,001) Net loss $ (141,483) $ (16,603,140) $ (16,744,623) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,279,556 54,279,556 Basic and Diluted net loss per Class A share $ — $ — Basic and Diluted weighted-average Class B ordinary shares outstanding 12,935,010 12,935,010 Basic and Diluted net loss per Class B share $ (0.01) $ (1.28) $ (1.29) Period From June 12, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (141,483) $ (16,603,140) $ (16,744,623) Adjustment to reconcile net loss to net cash used in operating activities (307,061) 16,603,140 16,296,079 Net cash used in operating activities (448,544) — (448,544) Net cash used in investing activities (543,986,470) — (543,986,470) Net cash provided by financing activities 545,413,196 — 545,413,196 Net change in cash $ 978,182 $ — $ 978,182

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	7 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of estimates	Use of estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2020.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. The Company’s investments held in the Trust Account as of December 31, 2020 is comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities money market funds.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, prepaid expenses accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. government securities with an original maturity of 185 days or less or investments in a money market funds that invest in only U.S. government securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets. The fair value of warrants issued in connection with the Initial Public Offering, exercise of the over-allotment option and Private Placement were initially and subsequently measured at fair value using a Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants have been measured based on the listed market price of such Public Warrants. The Private Placement Warrants continue to be measured at fair value using a Monte Carlo simulation model through December 31, 2020.
Offering Costs Associated with Initial Public Offering	Offering Costs Associated with Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity. Of the total offering costs of the Initial Public Offering, approximately $0.6 million is included in financing cost - derivative warrant liabilities in the statement of operations and $21.5 million is included in stockholders’ equity.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2020, 49,047,261 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the balance sheet.
Derivative Warrant liabilities	Derivative Warrant liabilities The Company did not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. Management evaluates all of its financial instruments, including issued warrants to purchase Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company issued an aggregate of 18,132,811 warrants on Class A ordinary shares in the Initial Public Offering and upon the underwriters exercise of a portion of their over-allotment option, and issued 6,519,791 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjusted the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering, exercise of the over-allotment option and Private Placement were initially and subsequently measured at fair value using a Monte Carlo simulation model. Beginning as of December 31, 2020, the fair value of Public Warrants have been measured based on the listed market price of such Public Warrants The Private Placement Warrants continue to be measured at fair value using a Monte Carlo simulation model through December 31, 2020.
Net Income (Loss) per Ordinary Share	Net Income (loss) per Ordinary Share Net loss per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 24,652,602 shares of Class A ordinary shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted loss per share is the same as basic loss per share for the periods presented. The Company’s statement of operations includes a presentation of income per share for Class A ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted, for Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account of approximately $18,000 for the period from June 12, 2020 (inception) through December 31, by the weighted average number of shares of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted, for Class B ordinary shares is calculated by dividing the net loss of approximately $17.6 million for the period from June 12, 2020 (inception) through December 31, 2020, less income attributable to Class A ordinary shares, by the weighted average number of shares of Class B ordinary shares outstanding for the period.
Income taxes	Income taxes FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent accounting pronouncements	Recent accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	7 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of the restatement on the audited consolidated balance sheets, statements of operations and statements of cash flows for the Affected Periods	As of December 31, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 545,277,797 $ — $ 545,277,797 Liabilities and shareholders’ equity Total current liabilities $ 444,449 $ — $ 444,449 Deferred underwriting commissions 13,614,452 — 13,614,452 Derivative warrant liabilities — 35,746,280 35,746,280 Total liabilities 14,058,901 35,746,280 49,805,181 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 526,218,890 (35,746,280) 490,472,610 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 178 357 535 Class B ordinary shares - $0.0001 par value 1,360 — 1,360 Additional paid-in-capital 5,518,316 17,095,843 22,614,159 Accumulated deficit (519,848) (17,096,200) (17,616,048) Total shareholders’ equity 5,000,006 — 5,000,006 Total liabilities and shareholders’ equity $ 545,277,797 $ — $ 545,277,797 Period From June 12, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Operations Loss from operations $ (538,313) $ — $ (538,313) Other (expense) income: Change in fair value of derivative warrant liabilities — (16,517,250) (16,517,250) Financing cost -derivative warrant liabilities — (578,950) (578,950) Net gain from investments held in Trust Account 18,465 — 18,465 Total other (expense) income 18,465 (17,096,200) (17,077,735) Net loss $ (519,848) $ (17,096,200) $ (17,616,048) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,364,337 54,364,337 Basic and Diluted net loss per Class A share $ 0.00 $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 13,269,125 13,269,125 Basic and Diluted net loss per Class B share $ (0.04) $ (1.29) $ (1.33) Period From June 12, 2020 (Inception) Through December 31, 2020 As Previously Restatement Reported Adjustment As Restated Statement of Cash Flows Net loss $ (519,848) $ (17,096,200) $ (17,616,048) Adjustment to reconcile net loss to net cash used in operating activities 32,456 17,096,200 17,128,656 Net cash used in operating activities (487,392) — (487,392) Net cash used in investing activities (543,984,330) — (543,984,330) Net cash provided by financing activities 545,413,196 — 545,413,196 Net change in cash $ 941,474 $ — $ 941,474 In addition, the impact to the balance sheet dated August 25, 2020, filed on Form 8-K on August 31, 2020 is presented below. As of August 25, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 503,263,387 $ — $ 503,263,387 Liabilities and shareholders’ equity Total current liabilities $ 1,044,874 $ — $ 1,044,874 Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 17,628,000 17,628,000 Total liabilities 13,119,874 17,628,000 30,747,874 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 485,143,510 (17,628,000) 467,515,510 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 149 176 325 Class B ordinary shares - $0.0001 par value 1,380 — 1,380 Additional paid-in-capital 5,028,513 578,774 5,607,287 Accumulated deficit (30,039) (578,950) (608,989) Total shareholders’ equity 5,000,003 — 5,000,003 Total liabilities and shareholders’ equity $ 503,263,387 $ — $ 503,263,387

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	7 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Schedule of Company's financial asset measured at fair value on recurring basis	Quoted Significant Significant Prices Other Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 544,002,795 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 26,292,580 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 9,453,700
Schedule of fair value hierarchy for liabilities measured at fair value on a recurring basis	The following table provides quantitative information regarding Level 3 fair value measurements inputs at the initial measurement date: As of August 25, 2020 As of December 31, 2020 Volatility Share price $ 9.74 $ 10.02 Risk-free rate Dividend yield
Summary of the changes in the fair value of Private Placement Warrants, a Level 3 liability, measured on a recurring basis.	Warrant liabilities at June 12, 2020 (inception) $ — Issuance of Public and Private Warrants 19,229,030 Change in fair value of warrant liabilities 16,517,250 Warrant liabilities at December 31, 2020 $ 35,746,280

QUARTERLY FINANCIAL INFORMATI_2

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Table)	7 Months Ended
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Table)	Dec. 31, 2020
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
Schedule of quarterly financial information	As of September 30, 2020 As Previously Restatement Reported Adjustment As Restated Balance Sheet Total assets $ 545,356,337 $ — $ 545,356,337 Liabilities and shareholders’ equity Total current liabilities $ 144,624 $ — $ 144,624 Deferred underwriting commissions 13,614,452 — 13,614,452 Derivative warrant liabilities — 35,253,220 35,253,220 Total liabilities 13,759,076 35,253,220 49,012,296 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 526,597,260 (35,253,220) 491,344,040 Preference shares - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 174 352 526 Class B ordinary shares - $0.0001 par value 1,379 — 1,379 Additional paid-in-capital 5,139,931 16,602,788 21,742,719 Accumulated deficit (141,483) (16,603,140) (16,744,623) Total shareholders’ equity 5,000,001 — 5,000,001 Total liabilities and shareholders’ equity $ 545,356,337 $ — $ 545,356,337 Three Months Ended September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (126,442) $ — $ (126,442) Other (expense) income: Change in fair value of derivative warrant liabilities — (16,024,190) (16,024,190) Financing cost - derivative warrant liabilities — (578,950) (578,950) Net gain from investments held in Trust Account 2,139 — 2,139 Total other (expense) income 2,139 (16,603,140) (16,601,001) Net loss $ (124,303) $ (16,603,140) $ (16,727,443) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,279,556 54,279,556 Basic and Diluted net loss per Class A share $ — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 12,935,010 12,935,010 Basic and Diluted net loss per Class B share $ (0.01) $ (1.28) $ (1.29) Period From June 12, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (143,622) $ — $ (143,622) Other (expense) income: Change in fair value of warrant liabilities — (16,024,190) (16,024,190) Financing cost — (578,950) (578,950) Net gain from investments held in Trust Account 2,139 — 2,139 Total other (expense) income 2,139 (16,603,140) (16,601,001) Net loss $ (141,483) $ (16,603,140) $ (16,744,623) Basic and Diluted weighted-average Class A ordinary shares outstanding 54,279,556 54,279,556 Basic and Diluted net loss per Class A share $ — $ — Basic and Diluted weighted-average Class B ordinary shares outstanding 12,935,010 12,935,010 Basic and Diluted net loss per Class B share $ (0.01) $ (1.28) $ (1.29) Period From June 12, 2020 (Inception) Through September 30, 2020 As Previously Restatement Reported Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (141,483) $ (16,603,140) $ (16,744,623) Adjustment to reconcile net loss to net cash used in operating activities (307,061) 16,603,140 16,296,079 Net cash used in operating activities (448,544) — (448,544) Net cash used in investing activities (543,986,470) — (543,986,470) Net cash provided by financing activities 545,413,196 — 545,413,196 Net change in cash $ 978,182 $ — $ 978,182

DESCRIPTION OF ORGANIZATION, _2

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION (Details) - USD ($)	Aug. 26, 2020	Aug. 25, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Offering costs			$ 8,165,986
Deferred underwriting commissions		$ 12,100,000	13,614,452
Cash underwriting fees			6,900,000
Investment of Cash into Trust Account			$ 543,984,330
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account			80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination			50.00%
Minimum net tangible assets upon consummation of the Business Combination			$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent			15.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)			100.00%
Threshold business days for redemption of public shares			10 days
Maximum net interest to pay dissolution expenses			$ 100,000
Cash operating bank account			941,474
Working capital			831,000
Aggregate purchase price			25,000
Loans from working capital			0
Sponsor \| Founder Shares
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price			25,000
Loan from the Sponsor			185,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	4,398,433	50,000,000
Share price per share	$ 10	$ 10
Aggregate amount for issuance of units	$ 44,000,000	$ 500,000,000
Offering costs	2,400,000	19,600,000
Deferred underwriting commissions	$ 1,500,000	$ 12,100,000
Initial Public Offering \| Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of units issued		15,500,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	4,398,433
Aggregate amount for issuance of units	$ 44,000,000
Deferred underwriting commissions	900,000
Cash underwriting fees	1,500,000
Amount deposited into Trust Account	$ 544,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Gross proceeds from sale of units		$ 8,900,000	$ 900,000
Number of warrants issued		5,933,333	586,458
Exercise price of warrants		$ 1.50	$ 1.50
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		5,933,333
Exercise price of warrants		$ 1.50
Proceeds from sale of Private Placement Warrants		$ 8,900,000
Private Placement Warrants \| Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		586,458
Exercise price of warrants		$ 1.50
Proceeds from sale of Private Placement Warrants		$ 900,000
Initial Public Offering and Private Placement
Subsidiary, Sale of Stock [Line Items]
Share price per share		$ 10
Aggregate proceeds held in the Trust Account		$ 500,000,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Impact of the Restatement - Balance Sheet (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 25, 2020	Jun. 11, 2020
BALANCE SHEET
Total assets	$ 545,277,797	$ 545,356,337	$ 503,263,387
Liabilities and shareholders' equity
Total current liabilities	444,449	144,624	1,044,874
Deferred underwriting commissions	13,614,452	13,614,452	12,075,000
Derivative warrant liabilities	35,746,280	35,253,220	17,628,000
Total liabilities	49,805,181	49,012,296	30,747,874
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders' equity	490,472,610	491,344,040	467,515,510
Additional paid-in capital	22,614,159	21,742,719	5,607,287
Accumulated deficit	(17,616,048)	(16,744,623)	(608,989)
Total shareholders' equity	5,000,006	5,000,001	5,000,003	$ 0
Total Liabilities and Shareholders' Equity	$ 545,277,797	$ 545,356,337	$ 503,263,387
Shares subject to possible redemption, par value per share	$ 10	$ 0.0001	$ 0.0001
Preference shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Class A ordinary shares
Liabilities and shareholders' equity
Ordinary shares	$ 535	$ 526	$ 325
Shares subject to possible redemption, par value per share	$ 0.0001
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Class B ordinary shares
Liabilities and shareholders' equity
Ordinary shares	$ 1,360	$ 1,379	$ 1,380
Additional paid-in capital	$ 22,614,159
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
As Previously Reported
BALANCE SHEET
Total assets	$ 545,277,797	$ 545,356,337	$ 503,263,387
Liabilities and shareholders' equity
Total current liabilities	444,449	144,624	1,044,874
Deferred underwriting commissions	13,614,452	13,614,452	12,075,000
Total liabilities	14,058,901	13,759,076	13,119,874
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders' equity	526,218,890	526,597,260	485,143,510
Additional paid-in capital	5,518,316	5,139,931	5,028,513
Accumulated deficit	(519,848)	(141,483)	(30,039)
Total shareholders' equity	5,000,006	5,000,001	5,000,003
Total Liabilities and Shareholders' Equity	545,277,797	545,356,337	503,263,387
As Previously Reported \| Class A ordinary shares
Liabilities and shareholders' equity
Ordinary shares	178	174	149
As Previously Reported \| Class B ordinary shares
Liabilities and shareholders' equity
Ordinary shares	1,360	1,379	1,380
Restatement Adjustment
Liabilities and shareholders' equity
Derivative warrant liabilities	35,746,280	35,253,220	17,628,000
Total liabilities	35,746,280	35,253,220	17,628,000
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders' equity	(35,746,280)	(35,253,220)	(17,628,000)
Additional paid-in capital	17,095,843	16,602,788	578,774
Accumulated deficit	(17,096,200)	(16,603,140)	(578,950)
Restatement Adjustment \| Class A ordinary shares
Liabilities and shareholders' equity
Ordinary shares	$ 357	$ 352	$ 176

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Impact of the Restatement - Statement of Operations (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
STATEMENTS OF OPERATIONS
Loss from operations	$ (126,442)	$ (143,622)	$ (538,313)
Other income:
Change in fair value of derivative warrant liabilities	16,024,190	16,024,190	(16,517,250)
Financing cost - derivative warrant liabilities	(578,950)	(578,950)	(578,950)
Net (gain) loss on investments held in Trust Account	2,139	2,139	(18,465)
Other Nonoperating Income (Expense), Total	(16,601,001)	(16,601,001)	(17,077,735)
Net loss	(16,727,443)	(16,744,623)	(17,616,048)
As Previously Reported
STATEMENTS OF OPERATIONS
Loss from operations	(126,442)	(143,622)	(538,313)
Other income:
Net (gain) loss on investments held in Trust Account	2,139	2,139	(18,465)
Other Nonoperating Income (Expense), Total	2,139	2,139	18,465
Net loss	(124,303)	(141,483)	(519,848)
Restatement Adjustment
Other income:
Change in fair value of derivative warrant liabilities	16,024,190	16,024,190	(16,517,250)
Financing cost - derivative warrant liabilities	(578,950)	(578,950)	(578,950)
Other Nonoperating Income (Expense), Total	(16,603,140)	(16,603,140)	(17,096,200)
Net loss	$ (16,603,140)	$ (16,603,140)	$ (17,096,200)
Class A ordinary shares
Other income:
Basic and Diluted weighted-average ordinary shares outstanding	54,279,556	54,279,556	54,364,337
Basic and Diluted net loss per share	$ 0		$ 0
Class A ordinary shares \| As Previously Reported
Other income:
Basic and Diluted weighted-average ordinary shares outstanding	54,279,556	54,279,556	54,364,337
Basic and Diluted net loss per share			$ 0
Class B ordinary shares
Other income:
Basic and Diluted weighted-average ordinary shares outstanding	12,935,010	12,935,010	13,269,125
Basic and Diluted net loss per share	$ (1.29)	$ (1.29)	$ (1.33)
Class B ordinary shares \| As Previously Reported
Other income:
Basic and Diluted weighted-average ordinary shares outstanding	12,935,010	12,935,010	13,269,125
Basic and Diluted net loss per share	$ (0.01)	$ (0.01)	$ (0.04)
Class B ordinary shares \| Restatement Adjustment
Other income:
Basic and Diluted net loss per share	$ (1.28)	$ (1.28)	$ (1.29)

RESTATEMENT OF PREVIOUSLY ISS_5

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Impact of the Restatement - Statement of Cash Flows (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF CASH FLOWS
Net loss	$ (16,727,443)	$ (16,744,623)	$ (17,616,048)
Adjustment to reconcile net loss to net cash used in operating activities		16,296,079	17,128,656
Net cash used in operating activities		448,544	(487,392)
Net cash used in investing activities		(543,986,470)	(543,984,330)
Net cash provided by financing activities		545,413,196	545,413,196
Net change in cash		978,182	941,474
Cash - beginning of the period		0	0
Cash - end of the period			941,474
As Previously Reported
STATEMENT OF CASH FLOWS
Net loss	(124,303)	(141,483)	(519,848)
Adjustment to reconcile net loss to net cash used in operating activities		(307,061)	32,456
Net cash used in operating activities		448,544	(487,392)
Net cash used in investing activities		(543,986,470)	(543,984,330)
Net cash provided by financing activities		545,413,196	545,413,196
Net change in cash		978,182	941,474
Restatement Adjustment
STATEMENT OF CASH FLOWS
Net loss	$ (16,603,140)	(16,603,140)	(17,096,200)
Adjustment to reconcile net loss to net cash used in operating activities		$ 16,603,140	$ 17,096,200

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of credit risk (Details)	7 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Maturity term of U.S. government securities	185 days

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Ordinary Shares subject to possible redemption (Details) - shares	Dec. 31, 2020	Sep. 30, 2020
Temporary Equity, Shares Outstanding	49,047,261
Class A ordinary shares
Temporary Equity, Shares Outstanding	49,047,261	49,047,261

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share, Income taxes (Details) - USD ($)	7 Months Ended
	Dec. 31, 2020	Oct. 04, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Unrecognized tax benefits	$ 0
Accrued interest and penalties	$ 0
Class A ordinary shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded since their inclusion would be anti-dilutive	24,652,602
Interest income earned on the Trust Account	$ 18,000
Class B ordinary shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Interest income earned on the Trust Account	$ 17,600,000
Over-allotment \| Class B ordinary shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Maximum shares subject to forfeiture		194,142

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Offering Costs Associated with Initial Public Offering (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Financing cost - derivative warrant liabilities	$ 578,950	$ 578,950	$ 578,950
Offering costs associated with the Public Shares			21,500,000
Derivative Warrant Liabilities
Financing cost - derivative warrant liabilities			$ 600,000

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivative Warrant liabilities (Details)	Dec. 31, 2020shares
Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants issued	18,132,811
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants issued	6,519,791

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Aug. 26, 2020	Aug. 25, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Proceeds received from initial public offering, gross		$ 500,000,000	$ 543,984,330
Offering costs			8,165,986
Deferred underwriting commissions		$ 12,100,000	$ 13,614,452
Exercise price of warrants			$ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	4,398,433	50,000,000
Price per share	$ 10	$ 10
Proceeds received from initial public offering, gross	$ 44,000,000
Offering costs	2,400,000	$ 19,600,000
Deferred underwriting commissions	$ 1,500,000	$ 12,100,000
Number of shares in a unit	1
Number of warrants in a unit	1
Exercise price of warrants			$ 11.50
Initial Public Offering \| Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of units issued		15,500,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of units issued	4,398,433
Deferred underwriting commissions	$ 900,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($) $ / shares in Units, $ in Millions	Aug. 25, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrant		$ 11.50
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	5,933,333	586,458
Price of warrants	$ 1.50	$ 1.50
Exercise price of warrant		$ 11.50
Total proceeds from sale of warrants	$ 8.9	$ 0.9

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Aug. 26, 2020shares	Aug. 25, 2020shares	Jul. 02, 2020USD ($)shares	Dec. 31, 2020USD ($)item$ / sharesshares	Oct. 04, 2020shares
Related Party Transaction [Line Items]
Aggregate purchase price \| $				$ 25,000
Over-allotment
Related Party Transaction [Line Items]
Number of shares forfeited					194,142
Sponsor \| Founder Shares
Related Party Transaction [Line Items]
Aggregate purchase price \| $				$ 25,000
Class B ordinary shares
Related Party Transaction [Line Items]
Number of shares forfeited			1,875,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Number of shares subject to forfeiture (in shares)			1,875,000	0
Ordinary shares, shares issued				13,599,608
Ordinary shares, shares outstanding				13,599,608
Class B ordinary shares \| Over-allotment
Related Party Transaction [Line Items]
Number of shares subject to forfeiture (in shares)				194,142
Class B ordinary shares \| Founder Shares
Related Party Transaction [Line Items]
Number of shares subject to forfeiture (in shares)	1,099,608
Class B ordinary shares \| Sponsor
Related Party Transaction [Line Items]
Number of shares issued			14,375,000
Aggregate purchase price \| $			$ 25,000
Class B ordinary shares \| Sponsor \| Founder Shares
Related Party Transaction [Line Items]
Number of shares surrendered		581,250
Number of shares subject to forfeiture (in shares)	1,099,608
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination				1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares				$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| item				20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| item				30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences				150 days

RELATED PARTY TRANSACTIONS - Re

RELATED PARTY TRANSACTIONS - Related Party Loans and Administrative Support Agreement (Details) - USD ($)	Aug. 28, 2020	Jul. 02, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Proceeds from Related Party Advances		$ 300,000
Repayment of advances from related party	$ 185,000
Amount agreed to pay to sponsor under administrative support agreement			$ 10,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum loans convertible into warrants			$ 1,500,000
Price of warrants (in dollars per share)			$ 1.50

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Underwriting Agreement (Details) - USD ($)	Aug. 26, 2020	Dec. 31, 2020	Aug. 25, 2020
Commitments And Contingencies [Line Items]
Underwriting discount per unit		$ 0.20
Deferred underwriting fee paid		$ 13,614,452	$ 12,100,000
Deferred fee per unit		$ 0.35
Underwriting discount amount paid		$ 6,900,000
Over-allotment
Commitments And Contingencies [Line Items]
Common Stock, Shares Authorized		7,500,000
Number of units issued	4,398,433
Unit price	$ 10
Deferred underwriting fee paid	$ 900,000
Underwriting discount amount paid	$ 1,500,000

DERIVATIVE WARRANT LIABILITES (

DERIVATIVE WARRANT LIABILITES (Details)	Dec. 31, 2020shares
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding	18,132,811
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding	6,519,791

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES (Details)	7 Months Ended
DERIVATIVE WARRANT LIABILITIES (Details)	Dec. 31, 2020item$ / shares
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 11.50
Redeemable warrants
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Public Warrants expiration term	5 years
Threshold period for filling registration statement after business combination	15 days
Fair market value per share	$ 0.361
Number of trading days on which fair market value of shares is reported \| item	10
Threshold issue price per share	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Adjustment of redemption price of stock based on market value and newly issued price 2 (as a percent)	180
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Redeemable warrants \| Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants \| item	20
Threshold business days before sending notice of redemption to warrant holders	30 days
Redeemable warrants \| Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 10
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants \| item	20
Threshold consecutive trading days for redemption of public warrants \| item	3
Threshold business days before sending notice of redemption to warrant holders	30 days
Redeemable warrants \| Redemption of Warrants When the Price per Share of Class A Common Stock Equals less than $10.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Threshold trading days for redemption of public warrants \| item	20
Threshold business days before sending notice of redemption to warrant holders	30 days

SHAREHOLDERS' EQUITY - Common S

SHAREHOLDERS' EQUITY - Common Stock Shares (Details)	Aug. 26, 2020shares	Aug. 25, 2020USD ($)$ / sharesshares	Jul. 02, 2020shares	Dec. 31, 2020Vote$ / sharesshares	Oct. 04, 2020shares	Sep. 30, 2020$ / sharesshares
Class of Stock [Line Items]
Shares subject to possible redemption				49,047,261
Class A ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)				400,000,000
Common shares, par value (in dollars per share) \| $ / shares		$ 0.0001		$ 0.0001		$ 0.0001
Common shares, votes per share \| Vote				1
common stock shares issued including shares subject to redemption				54,398,433
Common Stock Shares Outstanding Including Shares Subject To Redemption				54,398,433
Shares subject to possible redemption				49,047,261		49,047,261
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares				20.00%
Conversion ratio				1
Class B ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)				40,000,000
Common shares, par value (in dollars per share) \| $ / shares		$ 0.0001		$ 0.0001		$ 0.0001
common stock shares issued including shares subject to redemption			14,375,000
Common Stock Shares Outstanding Including Shares Subject To Redemption				13,599,608
Number Of Shares Subject To Forfeiture			1,875,000	0
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Class B ordinary shares \| Founder Shares
Class of Stock [Line Items]
Number Of Shares Subject To Forfeiture	1,099,608
Class B ordinary shares \| Sponsor \| Founder Shares
Class of Stock [Line Items]
Number Of Shares Subject To Forfeiture	1,099,608
Number of shares surrendered		581,250
Consideration on shares surrendered \| $		$ 0
Over-allotment
Class of Stock [Line Items]
Common shares, shares authorized (in shares)				7,500,000
Over-allotment \| Class B ordinary shares
Class of Stock [Line Items]
Number Of Shares Subject To Forfeiture				194,142
Maximum shares subject to forfeiture					194,142

SHAREHOLDERS' EQUITY - Preferre

SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details)	Dec. 31, 2020shares
SHAREHOLDERS' EQUITY
Preferred shares, shares authorized	1,000,000
Preferred shares, shares issued	0
Preferred shares, shares outstanding	0

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 25, 2020
Liabilities:
Derivative warrant liabilities	$ 35,746,280	$ 35,253,220	$ 17,628,000
Level 1
Assets:
Investments held in Trust Account	544,002,795
Level 1 \| Public Warrants
Liabilities:
Derivative warrant liabilities	26,292,580
Level 2
Assets:
Investments held in Trust Account	0
Level 3
Assets:
Investments held in Trust Account	0
Level 3 \| Private Placement Warrants
Liabilities:
Derivative warrant liabilities	$ 9,453,700

FAIR VALUE MEASUREMENTS -Level

FAIR VALUE MEASUREMENTS -Level 3 fair value measurements (Details) - Level 3	Dec. 31, 2020	Aug. 25, 2020
Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	22.1	15
Share price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	10.02	9.74
Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.36	0.53
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0	0

FAIR VALUE MEASUREMENTS - Deriv

FAIR VALUE MEASUREMENTS - Derivative warrant liabilities (Details)	7 Months Ended
	Dec. 31, 2020USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of Public and Private Warrants	$ 35,746,280
Change in fair value of warrant liabilities	16,517,250
Warrant liabilities at December 31, 2020	35,746,280
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of Public and Private Warrants	19,229,030
Warrant liabilities at December 31, 2020	$ 19,229,030

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional information (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in fair value of derivative warrant liabilities	$ (16,024,190)	$ (16,024,190)	$ 16,517,250
Public Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in fair value of derivative warrant liabilities			$ 16,500,000

QUARTERLY FINANCIAL INFORMATI_3

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Balance sheet (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 25, 2020	Jun. 11, 2020
BALANCE SHEET
Total assets	$ 545,277,797	$ 545,356,337	$ 503,263,387
Liabilities and Shareholders' Equity
Total current liabilities	444,449	144,624	1,044,874
Deferred underwriting commissions	13,614,452	13,614,452	12,075,000
Derivative warrant liabilities	35,746,280	35,253,220	17,628,000
Total liabilities	49,805,181	49,012,296	30,747,874
Class A ordinary shares; 49,047,261 shares subject to possible redemption at $10.00 per share	490,472,610	491,344,040	467,515,510
Additional paid-in capital	22,614,159	21,742,719	5,607,287
Accumulated deficit	(17,616,048)	(16,744,623)	(608,989)
Total shareholders' equity	5,000,006	5,000,001	5,000,003	$ 0
Total Liabilities and Shareholders' Equity	$ 545,277,797	$ 545,356,337	$ 503,263,387
Shares subject to possible redemption, par value per share	$ 10	$ 0.0001	$ 0.0001
Preference shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Class A ordinary shares
Liabilities and Shareholders' Equity
Ordinary shares	$ 535	$ 526	$ 325
Shares subject to possible redemption, par value per share	$ 0.0001
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
Class B ordinary shares
Liabilities and Shareholders' Equity
Ordinary shares	$ 1,360	$ 1,379	$ 1,380
Additional paid-in capital	$ 22,614,159
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
As Previously Reported
BALANCE SHEET
Total assets	$ 545,277,797	$ 545,356,337	$ 503,263,387
Liabilities and Shareholders' Equity
Total current liabilities	444,449	144,624	1,044,874
Deferred underwriting commissions	13,614,452	13,614,452	12,075,000
Total liabilities	14,058,901	13,759,076	13,119,874
Class A ordinary shares; 49,047,261 shares subject to possible redemption at $10.00 per share	526,218,890	526,597,260	485,143,510
Additional paid-in capital	5,518,316	5,139,931	5,028,513
Accumulated deficit	(519,848)	(141,483)	(30,039)
Total shareholders' equity	5,000,006	5,000,001	5,000,003
Total Liabilities and Shareholders' Equity	545,277,797	545,356,337	503,263,387
As Previously Reported \| Class A ordinary shares
Liabilities and Shareholders' Equity
Ordinary shares	178	174	149
As Previously Reported \| Class B ordinary shares
Liabilities and Shareholders' Equity
Ordinary shares	1,360	1,379	1,380
Restatement Adjustment
Liabilities and Shareholders' Equity
Derivative warrant liabilities	35,746,280	35,253,220	17,628,000
Total liabilities	35,746,280	35,253,220	17,628,000
Class A ordinary shares; 49,047,261 shares subject to possible redemption at $10.00 per share	(35,746,280)	(35,253,220)	(17,628,000)
Additional paid-in capital	17,095,843	16,602,788	578,774
Accumulated deficit	(17,096,200)	(16,603,140)	(578,950)
Restatement Adjustment \| Class A ordinary shares
Liabilities and Shareholders' Equity
Ordinary shares	$ 357	$ 352	$ 176

QUARTERLY FINANCIAL INFORMATI_4

QUARTERLY FINANCIAL INFORMATION - Statement of Operations (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
STATEMENTS OF OPERATIONS
Loss from operations	$ (126,442)	$ (143,622)	$ (538,313)
Other Nonoperating Income (Expense) [Abstract]
Change in fair value of derivative warrant liabilities	16,024,190	16,024,190	(16,517,250)
Financing cost - derivative warrant liabilities	(578,950)	(578,950)	(578,950)
Net (gain) loss on investments held in Trust Account	2,139	2,139	(18,465)
Other Nonoperating Income (Expense), Total	(16,601,001)	(16,601,001)	(17,077,735)
Net loss	$ (16,727,443)	$ (16,744,623)	$ (17,616,048)
Class A ordinary shares
Other Nonoperating Income (Expense) [Abstract]
Basic and diluted weighted average shares outstanding	54,279,556	54,279,556	54,364,337
Basic and diluted net income per share	$ 0		$ 0
Class B ordinary shares
Other Nonoperating Income (Expense) [Abstract]
Basic and diluted weighted average shares outstanding	12,935,010	12,935,010	13,269,125
Basic and diluted net income per share	$ (1.29)	$ (1.29)	$ (1.33)
As Previously Reported
STATEMENTS OF OPERATIONS
Loss from operations	$ (126,442)	$ (143,622)	$ (538,313)
Other Nonoperating Income (Expense) [Abstract]
Net (gain) loss on investments held in Trust Account	2,139	2,139	(18,465)
Other Nonoperating Income (Expense), Total	2,139	2,139	18,465
Net loss	$ (124,303)	$ (141,483)	$ (519,848)
As Previously Reported \| Class A ordinary shares
Other Nonoperating Income (Expense) [Abstract]
Basic and diluted weighted average shares outstanding	54,279,556	54,279,556	54,364,337
Basic and diluted net income per share			$ 0
As Previously Reported \| Class B ordinary shares
Other Nonoperating Income (Expense) [Abstract]
Basic and diluted weighted average shares outstanding	12,935,010	12,935,010	13,269,125
Basic and diluted net income per share	$ (0.01)	$ (0.01)	$ (0.04)
Restatement Adjustment
Other Nonoperating Income (Expense) [Abstract]
Change in fair value of derivative warrant liabilities	$ 16,024,190	$ 16,024,190	$ (16,517,250)
Financing cost - derivative warrant liabilities	(578,950)	(578,950)	(578,950)
Other Nonoperating Income (Expense), Total	(16,603,140)	(16,603,140)	(17,096,200)
Net loss	$ (16,603,140)	$ (16,603,140)	$ (17,096,200)
Restatement Adjustment \| Class B ordinary shares
Other Nonoperating Income (Expense) [Abstract]
Basic and diluted net income per share	$ (1.28)	$ (1.28)	$ (1.29)

QUARTERLY FINANCIAL INFORMATI_5

QUARTERLY FINANCIAL INFORMATION - Statement of Cash Flows (Details) - USD ($)	3 Months Ended	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
STATEMENT OF CASH FLOWS
Net loss	$ (16,727,443)	$ (16,744,623)	$ (17,616,048)
Adjustment to reconcile net loss to net cash used in operating activities		16,296,079	17,128,656
Net cash used in operating activities		448,544	(487,392)
Net cash used in investing activities		(543,986,470)	(543,984,330)
Net cash provided by financing activities		545,413,196	545,413,196
Net change in cash		978,182	941,474
Cash - beginning of the period		0	0
Cash - end of the period			941,474
As Previously Reported
STATEMENT OF CASH FLOWS
Net loss	(124,303)	(141,483)	(519,848)
Adjustment to reconcile net loss to net cash used in operating activities		(307,061)	32,456
Net cash used in operating activities		448,544	(487,392)
Net cash used in investing activities		(543,986,470)	(543,984,330)
Net cash provided by financing activities		545,413,196	545,413,196
Net change in cash		978,182	941,474
Restatement Adjustment
STATEMENT OF CASH FLOWS
Net loss	$ (16,603,140)	(16,603,140)	(17,096,200)
Adjustment to reconcile net loss to net cash used in operating activities		$ 16,603,140	$ 17,096,200